Cargando…

Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course

BACKGROUND AND PURPOSE: Thrombotic microangiopathy (TMA) is a group of microvascular occlusive disorders that presents with neurological involvement in up to 87% of the cases. Although the central nervous system (CNS) is an important target organ in TMA, the role of neurological manifestations in th...

Descripción completa

Detalles Bibliográficos
Autores principales: de Castro, José Thiago de Souza, Appenzeller, Simone, Colella, Marina Pereira, Yamaguti-Hayakawa, Gabriela, Paula, Erich Vinícius De, Annichinno-Bizzachi, Joyce, Cendes, Fernando, Fabiano, Reis, Orsi, Fernanda Andrade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491546/
https://www.ncbi.nlm.nih.gov/pubmed/36129939
http://dx.doi.org/10.1371/journal.pone.0272290
_version_ 1784793297289478144
author de Castro, José Thiago de Souza
Appenzeller, Simone
Colella, Marina Pereira
Yamaguti-Hayakawa, Gabriela
Paula, Erich Vinícius De
Annichinno-Bizzachi, Joyce
Cendes, Fernando
Fabiano, Reis
Orsi, Fernanda Andrade
author_facet de Castro, José Thiago de Souza
Appenzeller, Simone
Colella, Marina Pereira
Yamaguti-Hayakawa, Gabriela
Paula, Erich Vinícius De
Annichinno-Bizzachi, Joyce
Cendes, Fernando
Fabiano, Reis
Orsi, Fernanda Andrade
author_sort de Castro, José Thiago de Souza
collection PubMed
description BACKGROUND AND PURPOSE: Thrombotic microangiopathy (TMA) is a group of microvascular occlusive disorders that presents with neurological involvement in up to 87% of the cases. Although the central nervous system (CNS) is an important target organ in TMA, the role of neurological manifestations in the disease clinical course is not well established. In this study, we described the neurological manifestations and CNS radiological aspects in patients with a first, acute TMA event. We also examined the association between severe neurological involvement and adverse clinical outcomes in TMA. METHODS: A cohort of patients diagnosed with a first TMA event between 1995 and 2016 was included, their medical charts and imaging tests were retrospectively evaluated. RESULTS: A total of 49 patients were included, 85.7% were women and the mean age was 36.5 years-old (SD 13.0). Neurological manifestations were described in 85.7% of the patients, most of them (88%) were considered severe and consisted of confusion, compromised sensorimotor function, stupor, seizures, and personality change. Imaging tests were performed in 62% of the patients with neurological manifestations and detected acute CNS lesions, such as posterior reversible encephalopathy syndrome, hemorrhagic and ischemic stroke were observed, in 7 (27%) of them. While the need for intensive care unit admission was greater and longer among patients with severe neurological manifestations, the number of plasma exchange sessions, the total duration of hospitalization and in-hospital death were similar between groups. CONCLUSIONS: Severe neurological manifestations are common in first TMA events and are responsible for a worse disease presentation at admission. While the effect of neurological manifestations on acute TMA clinical course seems to be modest, these manifestations may have an important impact on the development of chronic cognitive impairment, which highlights the need for proper diagnosis and treatment.
format Online
Article
Text
id pubmed-9491546
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-94915462022-09-22 Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course de Castro, José Thiago de Souza Appenzeller, Simone Colella, Marina Pereira Yamaguti-Hayakawa, Gabriela Paula, Erich Vinícius De Annichinno-Bizzachi, Joyce Cendes, Fernando Fabiano, Reis Orsi, Fernanda Andrade PLoS One Research Article BACKGROUND AND PURPOSE: Thrombotic microangiopathy (TMA) is a group of microvascular occlusive disorders that presents with neurological involvement in up to 87% of the cases. Although the central nervous system (CNS) is an important target organ in TMA, the role of neurological manifestations in the disease clinical course is not well established. In this study, we described the neurological manifestations and CNS radiological aspects in patients with a first, acute TMA event. We also examined the association between severe neurological involvement and adverse clinical outcomes in TMA. METHODS: A cohort of patients diagnosed with a first TMA event between 1995 and 2016 was included, their medical charts and imaging tests were retrospectively evaluated. RESULTS: A total of 49 patients were included, 85.7% were women and the mean age was 36.5 years-old (SD 13.0). Neurological manifestations were described in 85.7% of the patients, most of them (88%) were considered severe and consisted of confusion, compromised sensorimotor function, stupor, seizures, and personality change. Imaging tests were performed in 62% of the patients with neurological manifestations and detected acute CNS lesions, such as posterior reversible encephalopathy syndrome, hemorrhagic and ischemic stroke were observed, in 7 (27%) of them. While the need for intensive care unit admission was greater and longer among patients with severe neurological manifestations, the number of plasma exchange sessions, the total duration of hospitalization and in-hospital death were similar between groups. CONCLUSIONS: Severe neurological manifestations are common in first TMA events and are responsible for a worse disease presentation at admission. While the effect of neurological manifestations on acute TMA clinical course seems to be modest, these manifestations may have an important impact on the development of chronic cognitive impairment, which highlights the need for proper diagnosis and treatment. Public Library of Science 2022-09-21 /pmc/articles/PMC9491546/ /pubmed/36129939 http://dx.doi.org/10.1371/journal.pone.0272290 Text en © 2022 de Castro et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
de Castro, José Thiago de Souza
Appenzeller, Simone
Colella, Marina Pereira
Yamaguti-Hayakawa, Gabriela
Paula, Erich Vinícius De
Annichinno-Bizzachi, Joyce
Cendes, Fernando
Fabiano, Reis
Orsi, Fernanda Andrade
Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course
title Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course
title_full Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course
title_fullStr Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course
title_full_unstemmed Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course
title_short Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course
title_sort neurological manifestations in thrombotic microangiopathy: imaging features, risk factors and clinical course
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491546/
https://www.ncbi.nlm.nih.gov/pubmed/36129939
http://dx.doi.org/10.1371/journal.pone.0272290
work_keys_str_mv AT decastrojosethiagodesouza neurologicalmanifestationsinthromboticmicroangiopathyimagingfeaturesriskfactorsandclinicalcourse
AT appenzellersimone neurologicalmanifestationsinthromboticmicroangiopathyimagingfeaturesriskfactorsandclinicalcourse
AT colellamarinapereira neurologicalmanifestationsinthromboticmicroangiopathyimagingfeaturesriskfactorsandclinicalcourse
AT yamagutihayakawagabriela neurologicalmanifestationsinthromboticmicroangiopathyimagingfeaturesriskfactorsandclinicalcourse
AT paulaerichviniciusde neurologicalmanifestationsinthromboticmicroangiopathyimagingfeaturesriskfactorsandclinicalcourse
AT annichinnobizzachijoyce neurologicalmanifestationsinthromboticmicroangiopathyimagingfeaturesriskfactorsandclinicalcourse
AT cendesfernando neurologicalmanifestationsinthromboticmicroangiopathyimagingfeaturesriskfactorsandclinicalcourse
AT fabianoreis neurologicalmanifestationsinthromboticmicroangiopathyimagingfeaturesriskfactorsandclinicalcourse
AT orsifernandaandrade neurologicalmanifestationsinthromboticmicroangiopathyimagingfeaturesriskfactorsandclinicalcourse